Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

The Inhalation and Nasal Spray Generic Drugs Market is taking a deep breath and preparing for a significant upswing. Expert ...

The collaboration combines Tenovi's Cellular Gateway and Modivcare's chronic condition management service offerings to create a cost-effective ecosystem that helps healthcare providers deliver a ...

Health experts have warned that turning on the central heating can make respiratory and sinus conditions worse as it causes ...

GSK Philippines Respiratory Syncytial Virus (RSV) is a common yet often overlooked respiratory virus. It spreads through coughing or sneezing and may cause symptoms like the flu or COVID-19.1 RSV is ...

One in 13 Australians over the age of 40 have chronic obstructive pulmonary disease (COPD), but alarmingly only half of them know they have ...

John Ruttle has a condition that kills 7600 Australians a year, but half of people with it don’t know it. One small tweak ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

What is this silent virus that endangers Filipino Seniors with comorbidities? Respiratory Syncytial Virus (RSV) is not just another cold or flu—it is potentially life- threatening for ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

GSK plc GSK announced positive data from the phase III ANCHOR-1 and ANCHOR-2 studies, which evaluated its pipeline candidate, ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...